icovamenib 100 mg for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Mar 2026: Trial registered, NCT07502508
  2. 30 Apr 2026: Trial started, NCT07502508

The trials

NCT07502508: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

State
Under way
Phase
Phase 2
People
60 planned
Started
30 Apr 2026
Primary completion
Jun 2027
Arms
Arm A: icovamenib 100 mg
Results
None posted
  1. 31 Mar 2026: Trial registered
  2. 30 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.